Papers
4
Total Citations
40
H-Index
3
About
Eu Chang Hwang is a urologic surgeon and researcher whose work focuses on advancing minimally invasive treatments for benign prostatic hyperplasia (BPH) and renal malignancies. His most impactful contribution is the landmark study on Aquablation therapy for BPH, a novel water-based, minimally invasive alternative to transurethral resection of the prostate (TURP). This work, with 29 citations, has helped establish Aquablation as a safe and effective option for men with lower urinary tract symptoms, offering reduced recovery times and preserved sexual function. Dr. Hwang has also investigated critical safety questions in robotic and laparoscopic partial nephrectomy, including whether surgical instruments can be reused after accidental tumor incision—an in vitro and in vivo study that addresses a practical concern in oncologic surgery. His comprehensive 28-year analysis of over 6,200 surgically treated renal masses in Korea provides valuable epidemiological and pathological trends, informing clinical decision-making. Additionally, his systematic review comparing suprapubic versus urethral catheter drainage in robotic-assisted prostatectomy contributes to evidence-based postoperative care. Through these contributions, Dr. Hwang has demonstrated a commitment to improving surgical outcomes and patient safety in urologic oncology and benign prostatic disease.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4